Additionally, heightened PRL-3 phosphatase activity in the healthy intestinal epithelium disrupts intestinal cell equilibrium, increasing vulnerability to PRL-3-mediated inflammation or mutation, which may lead to tumor development [122]. This evidence concerns the gene PTP4A3 and neoplasm.